Other

Research and development expenses

Roivant Sciences Research and development expenses decreased by 5.4% to $55.72M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 4.2%, from $53.47M to $55.72M. Over 3 years (FY 2021 to FY 2024), Research and development expenses shows a downward trend with a -11.5% CAGR.

Analysis

StatementBalance Sheet Statement
SectionOther
First reportedQ1 2022
Last reportedQ4 2025
Metric ID: other_accrued_research_and_development_expenses_current

Historical Data

15 periods
 Q1 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25
Value$66.19M$66.92M$56.33M$76.28M$57.16M$72.55M$43.63M$37.71M$46.46M$56.30M$53.47M$45.81M$49.80M$58.93M$55.72M
QoQ Change—+1.1%-15.8%+35.4%-25.1%+26.9%-39.9%-13.6%+23.2%+21.2%-5.0%-14.3%+8.7%+18.3%-5.4%
YoY Change———+15.2%—+8.4%-22.5%-50.6%-18.7%-22.4%+22.6%+21.5%+7.2%+4.7%+4.2%
Range$37.71M – $76.28M
CAGR-4.8%
Avg YoY Growth-2.8%
Median YoY Growth+4.7%

Frequently Asked Questions

What is Roivant Sciences's research and development expenses?
Roivant Sciences (ROIV) reported research and development expenses of $55.72M in Q4 2025.
How has Roivant Sciences's research and development expenses changed year-over-year?
Roivant Sciences's research and development expenses increased by 4.2% year-over-year, from $53.47M to $55.72M.
What is the long-term trend for Roivant Sciences's research and development expenses?
Over 3 years (2021 to 2024), Roivant Sciences's research and development expenses has grown at a -11.5% compound annual growth rate (CAGR), from $66.19M to $45.81M.